Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.

Campbell JR. et al, (2022), Emerging infectious diseases, 28, 1814 - 1823

Active screening for tuberculosis in high-incidence Inuit communities in Canada: a cost-effectiveness analysis.

Uppal A. et al, (2021), CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 193, E1652 - E1659

Dépistage actif chez les groupes courant un risque accru de contracter le SRAS-CoV-2 au Canada : coûts et ressources humaines nécessaires.

Campbell JR. et al, (2020), CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 192, E1734 - E1746

Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.

Campbell JR. et al, (2020), CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 192, E1146 - E1155

Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review.

Cormier M. et al, (2019), The Lancet. Global health, 7, e68 - e80